Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Athenex, Inc. (ATNX)  
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 91,730,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $0 - $0
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Athenex is a biopharmaceutical company focused on the discovery, development and commercialization of drugs for cancer treatment. Co.'s platforms are: Oncology Innovation Platform, which is focused on the research and development of its proprietary drugs; Commercial Platform, which is focused on the sales and marketing of its drugs and the market development of its proprietary drugs; and Global Supply Chain Platform, which provides supply of active pharmaceutical ingredients for its clinical and commercial efforts. Co.'s clinical pipeline in the Oncology Innovation Platform is derived from Cell Therapy, Orascovery, based on a P-glycoprotein pump inhibitor, and Src Kinase inhibition.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2025-02-02 2024-11-01 2024-05-03 2023-05-04

   
Records found: 371
  Page 1 of 15  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Lau Johnson Yiu Nam CEO and Chairman of the Board   •       •      –    2023-05-05 4 A $1.36 $11,400 D/D 8,382 250,397     -
   Kwan Rudolf EVP, Chief Medical Officer   •       –      –    2023-05-05 4 A $1.36 $4,900 D/D 3,603 49,816     -
   Cook Timothy Devere See Remarks   •       –      –    2023-05-05 4 A $1.36 $500 D/D 368 4,140     -
   Vierling John Director   –       •      –    2023-04-21 4 A $1.31 $8,499 D/D 6,513 12,329     -
   Tsang Benson Kwan Hung Director   –       •      –    2023-04-21 4 A $1.31 $11,501 D/D 8,813 16,920     -
   Wu Jinn Director   –       •      –    2023-04-21 4 A $1.31 $8,499 D/D 6,513 34,802     -
   Fok Manson Director   –       •      –    2023-04-21 4 A $1.31 $7,500 D/D 5,747 110,675     -
   Spiegel Robert J. Director   –       •      –    2023-04-21 4 A $1.31 $3,002 D/D 2,300 4,592     -
   Lau Johnson Yiu Nam CEO and Chairman of the Board   •       •      –    2023-04-21 4 A $1.31 $11,400 D/D 8,736 242,015     -
   Kwan Rudolf EVP, Chief Medical Officer   •       –      –    2023-04-21 4 A $1.31 $4,900 D/D 3,755 46,213     -
   Cook Timothy Devere See Remarks   •       –      –    2023-04-21 4 A $1.31 $500 D/D 383 3,772     -
   Davis Stephanie A Director   –       •      –    2023-04-21 4 A $1.31 $4,753 D/D 3,642 8,015     -
   Kwan Rudolf EVP, Chief Medical Officer   •       –      –    2023-04-07 4 A $1.22 $4,901 D/D 4,017 42,458     -
   Lau Johnson Yiu Nam CEO and Chairman of the Board   •       •      –    2023-04-07 4 A $1.22 $11,400 D/D 9,344 233,279     -
   Cook Timothy Devere See Remarks   •       –      –    2023-04-07 4 A $1.22 $500 D/D 410 3,389     -
   Lau Johnson Yiu Nam CEO and Chairman of the Board   •       •      –    2023-03-24 4 A $1.39 $11,399 D/D 8,201 223,935     -
   Cook Timothy Devere See Remarks   •       –      –    2023-03-24 4 A $1.39 $500 D/D 360 2,979     -
   Kwan Rudolf EVP, Chief Medical Officer   •       –      –    2023-03-24 4 A $1.39 $4,900 D/D 3,525 38,441     -
   Cook Timothy Devere See Remarks   •       –      –    2023-03-10 4 A $1.94 $501 D/D 258 2,619     -
   Lau Johnson Yiu Nam CEO and Chairman of the Board   •       •      –    2023-03-10 4 A $1.94 $10,707 D/D 5,519 215,734     -
   Kwan Rudolf EVP, Chief Medical Officer   •       –      –    2023-03-10 4 A $1.94 $4,900 D/D 2,526 34,916     -
   Kwan Rudolf EVP, Chief Medical Officer   •       –      –    2023-02-24 4 A $2.74 $4,899 D/D 1,788 32,390     -
   Lau Johnson Yiu Nam CEO and Chairman of the Board   •       •      –    2023-02-24 4 A $2.74 $4,359 D/D 1,591 210,215     -
   Cook Timothy Devere See Remarks   •       –      –    2023-02-24 4 A $2.74 $499 D/D 182 2,361     -
   Annoni Joe Chief Financial Officer   •       –      –    2023-02-22 4 D $2.66 $665 D/D (250) 375     -
  371 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 15
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us